[go: up one dir, main page]

Issaragrisil et al., 1995 - Google Patents

Collection of cord blood stem cells for transplantation in thalassemic patients

Issaragrisil et al., 1995

Document ID
15398421170801832103
Author
Issaragrisil S
Visuthisakchai S
Tangnaitrisorana Y
Piankijagum A
Chandanayingyong D
Suvatte V
Tanphaichitr V
Ruengvuttilert P
Publication year
Publication venue
Stem Cells

External Links

Snippet

Thalassemia is widely distributed throughout the world and is one of the major public health problems. The use of bone marrow transplantation, the only curative therapy for thalassemia, is limited because less than 30% of the patients have unaffected and HLA …
Continue reading at stemcellsjournals.onlinelibrary.wiley.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/44—Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0081—Purging biological preparations of unwanted cells
    • C12N5/0087—Purging against subsets of blood cells, e.g. purging alloreactive T cells

Similar Documents

Publication Publication Date Title
US6461645B1 (en) Isolation and preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood
EP0343217B1 (en) Isolation and preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood
JP6998911B2 (en) Composition for providing hematopoietic function without HLA conformance
JP7041179B2 (en) Compositions and Methods for Providing Hematopoietic Function
Ballen New trends in umbilical cord blood transplantation
Wagner et al. Allogeneic sibling umbilical-cord-blood transplantation in children with malignant and non-malignant disease
Page et al. Total colony-forming units are a strong, independent predictor of neutrophil and platelet engraftment after unrelated umbilical cord blood transplantation: a single-center analysis of 435 cord blood transplants
Armitage et al. Cord blood banking in London: the first 1000 collections
Elchalal et al. Postpartum umbilical cord blood collection for transplantation: a comparison of three methods
Fasouliotis et al. Human umbilical cord blood banking and transplantation: a state of the art
Wagner et al. Umbilical cord and placental blood hematopoietic stem cells: collection, cryopreservation, and storage
Warwick et al. Cord blood banking
Hare et al. Optimal umbilical cord blood collection, processing and cryopreservation methods for sustained public cord blood banking
Kögler et al. Haematopoietic transplant potential of unrelated and related cord blood: the first six years of the EUROCORD/NETCORD Bank Germany
JP2023078156A (en) Therapy with cells from human placenta and hematopoietic cells
Issaragrisil et al. Collection of cord blood stem cells for transplantation in thalassemic patients
Wagner Allogeneic umbilical cord blood transplantation
Katzenstein et al. Haploidentical related umbilical cord blood stem cell transplant in a child with acute non-lymphocytic leukemia
Shields et al. The use of CD34+ mobilized peripheral blood as a donor cell source does not improve chimerism after in utero hematopoietic stem cell transplantation in non‐human primates
Eliane et al. Hematopoietic reconstitution in a patient with Fanconi''s anemia by means of umbilical-cord blood from an HLA-identical sibling (1989)
Engelfriet et al. International forum. Use of umbilical cord blood progenitor cells as an alternative for bone marrow transplantation.
Wacharaprechanont et al. Cord blood collection for the national cord blood bank in Thailand
San Tang et al. Infectious Disease Testing to Optimize Safety of Hematopoietic Stem Cell Transplant Products
Murei Correlation OF CD34+ Stem Cell Yield Derived From Umbilical Cord Blood with Birth Weight, Gender, Placental Weight and Gestation Age at Kenyatta National Hospital in Kenya
Sharma et al. A study of 120 umbilical cord whole blood transfusions in 77 patients with different clinical conditions